USPTO serial 85706106
ALLEGRO ICLINICAL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHAN, ASMAT A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALLEGRO ICLINICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Craig A. Fieschko
CRAIG A. FIESCHKO DEWITT ROSS & STEVENS S.C.2 E MIFFLIN ST STE 600MADISON, WI 53703-2865UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Managing databases for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Managing databases for use by pharmaceutical companies and others in the data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures | ACTIVE | — |
| 042 | Providing on-line non-downloadable software for use in design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; providing a website featuring non-downloadable software for use in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining web sites, software, and applications for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining web sites, software, applications, and databases for use by pharmaceutical companies and others in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining web sites, software, and applications for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining web sites, software, and applications for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; consulting services regarding all of the foregoing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Forte Research Systems, Inc.
- Other trademarks owned by Forte Research Systems, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ALLEGRO ICLINICAL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2014 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 12, 2014 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 8, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 13, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 13, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 10, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 15, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 21, 2012 | NWAP | NEW APPLICATION ENTERED | — |